Financhill
Buy
61

MCO Quote, Financials, Valuation and Earnings

Last price:
$469.98
Seasonality move :
2.33%
Day range:
$467.73 - $474.24
52-week range:
$378.71 - $531.93
Dividend yield:
0.76%
P/E ratio:
40.59x
P/S ratio:
11.84x
P/B ratio:
22.86x
Volume:
798.8K
Avg. volume:
582.1K
1-year change:
11.19%
Market cap:
$84.6B
Revenue:
$7.1B
EPS (TTM):
$11.58
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $5.4B $6.2B $5.5B $5.9B $7.1B
Revenue Growth (YoY) 11.22% 15.77% -12.06% 8.19% 19.81%
 
Cost of Revenues $1.5B $1.6B $1.6B $1.7B $1.9B
Gross Profit $3.9B $4.6B $3.9B $4.2B $5.1B
Gross Profit Margin 72.54% 73.67% 70.5% 71.48% 72.56%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.2B $1.5B $1.5B $1.6B $1.7B
Other Inc / (Exp) -$13M $82M -$6M -$38M -$41M
Operating Expenses $1.4B $1.7B $1.9B $2B $2.2B
Operating Income $2.4B $2.8B $2B $2.2B $3B
 
Net Interest Expenses $205M $171M $231M $251M $237M
EBT. Incl. Unusual Items $2.2B $2.8B $1.8B $1.9B $2.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $452M $541M $386M $327M $640M
Net Income to Company $1.8B $2.2B $1.4B $1.6B $2.1B
 
Minority Interest in Earnings $1M -- -- -$1M -$1M
Net Income to Common Excl Extra Items $1.8B $2.2B $1.4B $1.6B $2.1B
 
Basic EPS (Cont. Ops) $9.48 $11.88 $7.47 $8.77 $11.32
Diluted EPS (Cont. Ops) $9.39 $11.78 $7.44 $8.73 $11.26
Weighted Average Basic Share $187.6M $186.4M $183.9M $183.2M $181.8M
Weighted Average Diluted Share $189.3M $187.9M $184.7M $184M $182.7M
 
EBITDA $2.7B $3.2B $2.3B $2.6B $3.5B
EBIT $2.4B $3B $2B $2.3B $3B
 
Revenue (Reported) $5.4B $6.2B $5.5B $5.9B $7.1B
Operating Income (Reported) $2.4B $2.8B $2B $2.2B $3B
Operating Income (Adjusted) $2.4B $3B $2B $2.3B $3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.6B $1.5B $1.5B $1.8B $1.9B
Revenue Growth (YoY) 24.03% -4.88% -3.42% 21.5% 7.73%
 
Cost of Revenues $393M $417M $428M $467M $491M
Gross Profit $1.2B $1.1B $1B $1.3B $1.4B
Gross Profit Margin 75.44% 72.6% 70.88% 73.85% 74.48%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $293M $371M $386M $413M $439M
Other Inc / (Exp) $14M $6M -$14M $8M -$16M
Operating Expenses $352M $449M $474M $513M $552M
Operating Income $855M $656M $568M $806M $881M
 
Net Interest Expenses $7M $53M $48M $62M $61M
EBT. Incl. Unusual Items $862M $609M $506M $752M $804M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $126M $111M $5M $175M $179M
Net Income to Company $736M $498M $501M $577M $625M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $736M $498M $501M $577M $625M
 
Basic EPS (Cont. Ops) $3.93 $2.69 $2.73 $3.16 $3.47
Diluted EPS (Cont. Ops) $3.90 $2.68 $2.72 $3.15 $3.46
Weighted Average Basic Share $187.2M $185.1M $183.3M $182.6M $180M
Weighted Average Diluted Share $188.6M $186.1M $184.1M $183.4M $180.7M
 
EBITDA $966M $742M $670M $936M $1B
EBIT $907M $664M $582M $836M $889M
 
Revenue (Reported) $1.6B $1.5B $1.5B $1.8B $1.9B
Operating Income (Reported) $855M $656M $568M $806M $881M
Operating Income (Adjusted) $907M $664M $582M $836M $889M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $5.7B $6.1B $5.4B $6.2B $7.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.5B $1.7B $1.6B $1.7B $2B
Gross Profit $4.2B $4.5B $3.8B $4.5B $5.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.2B $1.6B $1.5B $1.7B $1.8B
Other Inc / (Exp) -$3M $74M -$26M -$16M -$65M
Operating Expenses $1.5B $1.8B $1.9B $2B $2.2B
Operating Income $2.7B $2.6B $1.9B $2.5B $3.1B
 
Net Interest Expenses $172M $217M $226M $265M $236M
EBT. Incl. Unusual Items $2.5B $2.5B $1.7B $2.2B $2.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $501M $526M $280M $497M $644M
Net Income to Company $2B $2B $1.4B $1.7B $2.1B
 
Minority Interest in Earnings -- -- -- -$1M -$1M
Net Income to Common Excl Extra Items $2B $2B $1.4B $1.7B $2.1B
 
Basic EPS (Cont. Ops) $10.80 $10.63 $7.50 $9.19 $11.62
Diluted EPS (Cont. Ops) $10.72 $10.56 $7.48 $9.16 $11.58
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $3B $3B $2.3B $2.9B $3.5B
EBIT $2.7B $2.7B $1.9B $2.5B $3.1B
 
Revenue (Reported) $5.7B $6.1B $5.4B $6.2B $7.2B
Operating Income (Reported) $2.7B $2.6B $1.9B $2.5B $3.1B
Operating Income (Adjusted) $2.7B $2.7B $1.9B $2.5B $3.1B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.6B $1.5B $1.5B $1.8B $1.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $393M $417M $428M $467M $491M
Gross Profit $1.2B $1.1B $1B $1.3B $1.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $293M $371M $386M $413M $439M
Other Inc / (Exp) $14M $6M -$14M $8M -$16M
Operating Expenses $352M $449M $474M $513M $552M
Operating Income $855M $656M $568M $806M $881M
 
Net Interest Expenses $7M $53M $48M $62M $61M
EBT. Incl. Unusual Items $862M $609M $506M $752M $804M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $126M $111M $5M $175M $179M
Net Income to Company $736M $498M $501M $577M $625M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $736M $498M $501M $577M $625M
 
Basic EPS (Cont. Ops) $3.93 $2.69 $2.73 $3.16 $3.47
Diluted EPS (Cont. Ops) $3.90 $2.68 $2.72 $3.15 $3.46
Weighted Average Basic Share $187.2M $185.1M $183.3M $182.6M $180M
Weighted Average Diluted Share $188.6M $186.1M $184.1M $183.4M $180.7M
 
EBITDA $966M $742M $670M $936M $1B
EBIT $907M $664M $582M $836M $889M
 
Revenue (Reported) $1.6B $1.5B $1.5B $1.8B $1.9B
Operating Income (Reported) $855M $656M $568M $806M $881M
Operating Income (Adjusted) $907M $664M $582M $836M $889M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $2.6B $1.8B $1.8B $2.1B $2.4B
Short Term Investments $99M $91M $90M $63M $566M
Accounts Receivable, Net $1.4B $1.7B $1.7B $1.7B $1.8B
Inventory -- -- -- -- --
Prepaid Expenses $185M $211M $354M $248M $260M
Other Current Assets $167M $177M $136M $149M $178M
Total Current Assets $4.5B $4B $4.1B $4.3B $5.3B
 
Property Plant And Equipment $671M $785M $848M $880M $872M
Long-Term Investments $201M $532M $604M $621M $563M
Goodwill $4.6B $6B $5.8B $6B $6B
Other Intangibles $1.8B $2.5B $2.2B $2B $1.9B
Other Long-Term Assets $83M $207M $235M $261M $256M
Total Assets $12.4B $14.7B $14.3B $14.6B $15.5B
 
Accounts Payable $39M $47M $52M $23M $53M
Accrued Expenses $507M $465M $480M $473M $486M
Current Portion Of Long-Term Debt -- -- -- -- $697M
Current Portion Of Capital Lease Obligations $94M $105M $106M $108M $102M
Other Current Liabilities $41M $12M $2M -- $24M
Total Current Liabilities $2.2B $2.5B $2.4B $2.5B $3.6B
 
Long-Term Debt $6.4B $7.4B $7.4B $7B $6.7B
Capital Leases -- -- -- -- --
Total Liabilities $10.6B $11.8B $11.7B $11.1B $11.8B
 
Common Stock $3M $3M $3M $3M $3M
Other Common Equity Adj -$432M -$410M -$643M -$567M -$638M
Common Equity $1.6B $2.7B $2.5B $3.3B $3.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $194M $189M $170M $158M $162M
Total Equity $1.8B $2.9B $2.7B $3.5B $3.7B
 
Total Liabilities and Equity $12.4B $14.7B $14.3B $14.6B $15.5B
Cash and Short Terms $2.7B $1.9B $1.9B $2.2B $3B
Total Debt $6.4B $7.4B $7.4B $7B $7.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $2.8B $1.8B $2.1B $2.5B $2.1B
Short Term Investments $96M $103M $78M $58M $62M
Accounts Receivable, Net $1.5B $1.8B $1.7B $1.8B $1.9B
Inventory -- -- -- -- --
Prepaid Expenses $161M $217M $322M $234M $284M
Other Current Assets $141M $157M $191M $154M $180M
Total Current Assets $4.7B $4.1B $4.4B $4.8B $4.6B
 
Property Plant And Equipment $644M $808M $857M $873M $888M
Long-Term Investments $216M $523M $609M $632M $594M
Goodwill $4.6B $6B $5.9B $5.9B $6.2B
Other Intangibles $1.8B $2.4B $2.2B $2B $2B
Other Long-Term Assets $106M $231M $241M $265M $238M
Total Assets $12.5B $14.7B $14.7B $15B $15.1B
 
Accounts Payable $21M $42M $70M $88M $98M
Accrued Expenses $466M $453M $441M $466M $450M
Current Portion Of Long-Term Debt -- $501M $499M $685M --
Current Portion Of Capital Lease Obligations $94M $106M $106M $109M $103M
Other Current Liabilities $28M $22M $1M $18M $18M
Total Current Liabilities $2.2B $3B $3B $3.4B $2.9B
 
Long-Term Debt $6.3B $7.3B $7B $6.3B $6.8B
Capital Leases -- -- -- -- --
Total Liabilities $10.3B $12.2B $11.7B $11.3B $11.2B
 
Common Stock $3M $3M $3M $3M $3M
Other Common Equity Adj -$440M -$471M -$589M -$608M -$578M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $195M $188M $167M $160M $158M
Total Equity $2.2B $2.6B $3.1B $3.7B $3.9B
 
Total Liabilities and Equity $12.5B $14.7B $14.7B $15B $15.1B
Cash and Short Terms $2.9B $1.9B $2.2B $2.5B $2.2B
Total Debt $6.3B $7.8B $7.5B $6.9B $6.8B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $1.8B $2.2B $1.4B $1.6B $2.1B
Depreciation & Amoritzation $220M $257M $331M $373M $431M
Stock-Based Compensation $154M $175M $169M $193M $220M
Change in Accounts Receivable $31M -$270M $9M -$12M -$187M
Change in Inventories -- -- -- -- --
Cash From Operations $2.1B $2B $1.5B $2.2B $2.8B
 
Capital Expenditures $103M $139M $283M $271M $317M
Cash Acquisitions -$897M -$2.4B -$169M $5M -$223M
Cash From Investing -$1.1B -$2.6B -$262M -$247M -$1.1B
 
Dividends Paid (Ex Special Dividend) -$420M -$463M -$515M -$564M -$620M
Special Dividend Paid
Long-Term Debt Issued $2.3B $1.7B $988M -- $496M
Long-Term Debt Repaid -$1.6B -$500M -$626M -$500M --
Repurchase of Common Stock -$503M -$750M -$1.1B -$561M -$1.4B
Other Financing Activities -$63M -$36M -$11M -$9M -$12M
Cash From Financing -$351M -$122M -$1.2B -$1.6B -$1.4B
 
Beginning Cash (CF) $1.8B $2.6B $1.8B $1.8B $2.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $718M -$736M $4M $320M $336M
Ending Cash (CF) $2.6B $1.8B $1.8B $2.1B $2.4B
 
Levered Free Cash Flow $2B $1.9B $1.2B $1.9B $2.5B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $736M $498M $501M $577M $625M
Depreciation & Amoritzation $59M $78M $88M $100M $113M
Stock-Based Compensation $45M $46M $47M $53M $56M
Change in Accounts Receivable -$71M -$117M -$54M -$197M -$16M
Change in Inventories -- -- -- -- --
Cash From Operations $676M $470M $608M $775M $757M
 
Capital Expenditures $14M $59M $73M $78M $85M
Cash Acquisitions -$138M -$83M -- -$14M -$233M
Cash From Investing -$194M -$161M -$63M -$96M $224M
 
Dividends Paid (Ex Special Dividend) -$116M -$130M -$141M -$155M -$195M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $491M -- -- --
Long-Term Debt Repaid -- -- -- -- -$700M
Repurchase of Common Stock -$132M -$560M -- -- --
Other Financing Activities -- -$103M -- -- --
Cash From Financing -$290M -$352M -$216M -$308M -$1.3B
 
Beginning Cash (CF) $2.6B $1.8B $1.8B $2.1B $2.4B
Foreign Exchange Rate Adjustment -$20M -$18M $21M -$25M $48M
Additions / Reductions $192M -$43M $329M $371M -$317M
Ending Cash (CF) $2.8B $1.8B $2.1B $2.5B $2.1B
 
Levered Free Cash Flow $662M $411M $535M $697M $672M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $2B $2B $1.4B $1.7B $2.1B
Depreciation & Amoritzation $230M $276M $341M $385M $444M
Stock-Based Compensation $162M $176M $170M $199M $223M
Change in Accounts Receivable -$33M -$316M $72M -$155M -$6M
Change in Inventories -- -- -- -- --
Cash From Operations $2.5B $1.8B $1.6B $2.3B $2.8B
 
Capital Expenditures $96M $184M $297M $276M $324M
Cash Acquisitions -$339M -$2.4B -$86M -$9M -$442M
Cash From Investing -$499M -$2.6B -$164M -$280M -$736M
 
Dividends Paid (Ex Special Dividend) -$431M -$477M -$526M -$578M -$660M
Special Dividend Paid
Long-Term Debt Issued $791M $2.2B -- -- --
Long-Term Debt Repaid -- -- -- -$500M -$700M
Repurchase of Common Stock -$382M -$1.2B -- -- --
Other Financing Activities -- -$139M -- -- --
Cash From Financing -$1.4B -$184M -$1.1B -$1.7B -$2.4B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $572M -$971M $376M $362M -$352M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.4B $1.6B $1.3B $2B $2.5B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $736M $498M $501M $577M $625M
Depreciation & Amoritzation $59M $78M $88M $100M $113M
Stock-Based Compensation $45M $46M $47M $53M $56M
Change in Accounts Receivable -$71M -$117M -$54M -$197M -$16M
Change in Inventories -- -- -- -- --
Cash From Operations $676M $470M $608M $775M $757M
 
Capital Expenditures $14M $59M $73M $78M $85M
Cash Acquisitions -$138M -$83M -- -$14M -$233M
Cash From Investing -$194M -$161M -$63M -$96M $224M
 
Dividends Paid (Ex Special Dividend) -$116M -$130M -$141M -$155M -$195M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $491M -- -- --
Long-Term Debt Repaid -- -- -- -- -$700M
Repurchase of Common Stock -$132M -$560M -- -- --
Other Financing Activities -- -$103M -- -- --
Cash From Financing -$290M -$352M -$216M -$308M -$1.3B
 
Beginning Cash (CF) $2.6B $1.8B $1.8B $2.1B $2.4B
Foreign Exchange Rate Adjustment -$20M -$18M $21M -$25M $48M
Additions / Reductions $192M -$43M $329M $371M -$317M
Ending Cash (CF) $2.8B $1.8B $2.1B $2.5B $2.1B
 
Levered Free Cash Flow $662M $411M $535M $697M $672M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Take-Two Stock Go?
How High Will Take-Two Stock Go?

Take-Two Interactive (NASDAQ:TTWO) is the video game development company behind…

Where Will Target’s Stock Be in 10 Years?
Where Will Target’s Stock Be in 10 Years?

If you could hop into a time machine and land…

Why Did Stan Druckenmiller Buy DocuSign?
Why Did Stan Druckenmiller Buy DocuSign?

Billionaire Stanley Druckenmiller’s Duquesne Family Office portfolio is always worth…

Stock Ideas

Buy
64
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
37
RGC alert for Jun 21

Regencell Bioscience Holdings [RGC] is down 40.02% over the past day.

Buy
83
GMS alert for Jun 21

GMS [GMS] is up 23.79% over the past day.

Buy
57
QNTM alert for Jun 21

Quantum BioPharma [QNTM] is up 13.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock